Swiss drugmaker Novartis is buying Vedere Bio, hoping gene therapy technology that has helped blind mice to see will produce similar results in people with inherited conditions that cause them to lose ...

Nvidia's strategic investments with Intel, OpenAI, and more drive growth and valuation. Click here to read my most recent ...

Rankings still matter, but AI visibility is rising fast. Learn how to measure and maximize your presence in ChatGPT, AI ...

The Institutes RiskStream Collaborative and BluePond.AI announced a strategic partnership to address one of the property and casualty insurance sector's most persistent challenges: the broken flow of ...

Boomi, the leader in AI-driven automation, today announced the general availability of native Change Data Capture (CDC) ...